rs200725073
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP3BS1_Supporting
The NM_138773.4(SLC25A46):c.746G>A(p.Gly249Asp) variant causes a missense change. The variant allele was found at a frequency of 0.000111 in 1,613,504 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_138773.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC25A46 | NM_138773.4 | c.746G>A | p.Gly249Asp | missense_variant | Exon 8 of 8 | ENST00000355943.8 | NP_620128.1 | |
SLC25A46 | NM_001303250.3 | c.473G>A | p.Gly158Asp | missense_variant | Exon 8 of 8 | NP_001290179.1 | ||
SLC25A46 | NM_001303249.3 | c.679-176G>A | intron_variant | Intron 7 of 7 | NP_001290178.1 | |||
SLC25A46 | NR_138151.2 | n.985G>A | non_coding_transcript_exon_variant | Exon 9 of 9 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152052Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000479 AC: 12AN: 250778Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135528
GnomAD4 exome AF: 0.000118 AC: 173AN: 1461452Hom.: 0 Cov.: 31 AF XY: 0.000132 AC XY: 96AN XY: 727022
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152052Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74260
ClinVar
Submissions by phenotype
Neuropathy, hereditary motor and sensory, type 6B Pathogenic:1Uncertain:1
- -
This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 249 of the SLC25A46 protein (p.Gly249Asp). This variant is present in population databases (rs200725073, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of SLC25A46-related conditions and/or optic atrophy and axonal peripheral neuropathy (PMID: 26168012, 33841295). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 372238). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SLC25A46 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change does not substantially affect SLC25A46 function (PMID: 27543974). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.746G>A (p.G249D) alteration is located in exon 8 (coding exon 8) of the SLC25A46 gene. This alteration results from a G to A substitution at nucleotide position 746, causing the glycine (G) at amino acid position 249 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at